1. Home
  2. PRAX vs ALSN Comparison

PRAX vs ALSN Comparison

Compare PRAX & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.29

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Allison Transmission Holdings Inc.

ALSN

Allison Transmission Holdings Inc.

HOLD

Current Price

$130.00

Market Cap

9.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
ALSN
Founded
2015
1915
Country
United States
United States
Employees
N/A
4000
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.9B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
PRAX
ALSN
Price
$337.29
$130.00
Analyst Decision
Strong Buy
Hold
Analyst Count
15
7
Target Price
$572.13
$117.57
AVG Volume (30 Days)
326.2K
677.9K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
0.84%
EPS Growth
N/A
N/A
EPS
N/A
7.33
Revenue
N/A
$3,010,000,000.00
Revenue This Year
N/A
$94.98
Revenue Next Year
$7,758.26
$5.30
P/E Ratio
N/A
$17.94
Revenue Growth
N/A
N/A
52 Week Low
$34.89
$76.01
52 Week High
$354.87
$137.62

Technical Indicators

Market Signals
Indicator
PRAX
ALSN
Relative Strength Index (RSI) 55.91 54.54
Support Level $282.49 $110.01
Resistance Level $353.83 $137.62
Average True Range (ATR) 18.75 3.50
MACD -0.96 -0.41
Stochastic Oscillator 69.67 41.46

Price Performance

Historical Comparison
PRAX
ALSN

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: